Skip to main content
Pharmaco Vigilance
Search form
Search
Home
Perspectives
Case Reports
Focus on
Columns
News
Links
About us
Contacts
News
November 2021
Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial
October 2021
Association of Receipt of the Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barré Syndrome, February-July 2021
October 2021
Surveillance for Adverse Events After COVID-19 mRNA Vaccination
October 2021
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)
September 2021
No Correlation between Anti-PF4 and Anti–SARS-CoV-2 Antibodies after ChAdOx1 nCoV-19 Vaccination
September 2021
Rate of Recurrent Guillain-Barré Syndrome After mRNA COVID-19 Vaccine BNT162b2
September 2021
Surveillance for Adverse Events After COVID-19 mRNA Vaccination
July 2021
Incidence of Cutaneous Reactions After Messenger RNA COVID-19 Vaccines
July 2021
Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination
July 2021
Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
80.211.154.110
